LSE:AZN 8 August 2025 - 9 July 2026

FTSE 100 Drops as AstraZeneca Hit Pounds London Shares
···

London stocks lagged Tuesday as FTSE 100 missed surge in other corners

The FTSE 100 edged lower Thursday, though the main index drop didn’t tell the whole story. A big pharmaceutical stock weighed on the benchmark, but banks, miners, tech names and mid-cap shares all moved up in the background. FTSE 100 slipped 0.2% to 10,472.5. Gains in banks, up 2.2%, and miners, both industrial and precious-metal names, up over 4%, couldn’t make up for AstraZeneca’s trial news. The FTSE 250 added 1.0%, breaking a three-day losing streak and suggesting investors aren’t just pulling out of UK names.
July 9, 2026
AstraZeneca shares fall after Wainua trial miss leaves door open for rivals
··

AstraZeneca shares fall after Wainua trial miss leaves door open for rivals

AstraZeneca stock fell Thursday after its Wainua drug, co-developed with Ionis Pharmaceuticals, did not meet the main goal in a late-stage study for a rare heart disease. The setback deals a blow to one of AstraZeneca’s high-profile programs outside cancer. AstraZeneca is looking for new drugs to push revenue to $80 billion by 2030, up from $45.8 billion last year. The company aims to launch 20 new medicines by the end of the decade. The timing isn’t great.
July 9, 2026
FTSE 100 Drops as AstraZeneca Hit Pounds London Shares
·

FTSE 100 Drops as AstraZeneca Hit Pounds London Shares

FTSE 100 finished lower Thursday, weighed down by AstraZeneca after the pharma giant missed on a key late-stage trial. That left the London blue-chip index trailing gains seen in the rest of Europe. The blue-chip index, which tracks the 100 largest London-listed firms by market cap, dropped 0.61% to 10,424.59 at 13:48 BST, according to delayed data. The day's range ran from 10,397.48 to 10,539.47. Google Finance data showed the FTSE 250 mid-cap index ahead 0.28%, showing a mixed session rather than a larger London selloff.
July 9, 2026
FTSE 100 edges lower as deal risk holds easyJet bid gap
···

FTSE 100 edges lower as deal risk holds easyJet bid gap

London trade was done for the day at this point; the LSE runs from 0800 to 1630 BST on weekdays. The decline wasn't across the board. Losses in several bigger names weighed on the index, but some deal names and banks limited the drop. The FTSE 100 ended down 27.26 points at 10,651.77, according to market-data streams. The index hit 10,733.39 earlier in the day but finished around 2.6% under its all-time high from February 2026 at 10,934.94. It's still up 20.95% over the last year.
July 6, 2026
FTSE 100 edges up, but UK mid-caps slide after credit worries
······

FTSE 100 edges up, but UK mid-caps slide after credit worries

The FTSE 100 edged higher late Thursday morning, but the main story was away from the headline number. Trading Economics showed its FTSE 100 GB100 CFD at 10,528.33, up 0.48%. But Sharecast’s 0834 BST snapshot had the FTSE 100 off 0.07% at 10,470.93 and the FTSE 250 0.58% lower at 23,194.67. Early moves showed small caps got hit harder on guidance. Sharecast’s table said the 10 worst FTSE 250 names dropped an average 4.10%. That compares to a 1.46% average drop for the 10 worst FTSE 100 stocks. The biggest FTSE 100 gainers rose an average 1.76%. Food retail, luxury and exchange infrastructure names led on the upside.
July 2, 2026
FTSE 250 outpaces FTSE 100 as domestic and defence names help London market
········

FTSE 250 outpaces FTSE 100 as domestic and defence names help London market

FTSE 250 outperformed the FTSE 100 on Wednesday as mid-caps climbed 1.38% to their highest in a week. The FTSE 100 slipped 0.18%, weighed down by declines in healthcare and oil heavyweights. Regular London trading hours were 0800 to 1630 local, as usual. The spread suggested the trade was cleaner than the main index let on. Dollar earners in the FTSE 100 with heavy exports got hit by declines in oil and pharma. Domestic and specialist mid-caps saw buyers step in, though the Bank of England offered no signal on rate cuts.
July 1, 2026
UK & AU Stock Market Today: Live Updates 21.06.2026
···

UK & AU Stock Market Today: Live Updates 21.06.2026

LIVEMarkets rolling coverageStarted: June 21, 2026, 4:00 AM EDTUpdated: June 22, 2026, 3:58 AM EDT National Grid Shares Down 15%: Is It a Buying Opportunity? June 22, 2026, 3:58 AM EDT. National Grid’s shares have dropped 15% since March 2, hitting a one-year low of £12.09, prompting debate over whether this decline signals a bargain. While market price reflects current trading, value is anchored in the company’s future earnings potential. Analysts highlight that National Grid’s forward price-to-earnings ratio is 13.5, below the peer average of 16, suggesting relative cheapness on earnings, despite a higher price-to-sales ratio of 3 versus 1.4
June 21, 2026
UK Stock Market Today: FTSE 100 Is Closed, But Tuesday’s Oil Test Looks Bigger Now
······

UK Stock Market Today: FTSE 100 Is Closed, But Tuesday’s Oil Test Looks Bigger Now

With London markets shut Monday for the Early May Bank Holiday, the FTSE 100 sat out the latest round of global selling. The London Stock Exchange had flagged May 4 as a non-trading and non-settlement day for sterling trades. This time, UK investors come back on Tuesday to a different landscape: oil prices have jumped, European stocks slid, and the Middle East is once again squarely on traders’ radar. The FTSE 100 leans hard toward energy, mining, banks, and global pharma giants—so while a holiday may push back the reaction, it won’t prevent the market from catching up.
May 4, 2026
UK Stock Market Today: FTSE 100 Slips As BP, Shell And AstraZeneca Drag London Shares Lower
········

UK Stock Market Today: FTSE 100 Slips As BP, Shell And AstraZeneca Drag London Shares Lower

FTSE 100 slipped 0.1% to finish at 10,363.93 on Friday, chalking up its third consecutive weekly drop as London heads into a long weekend. The UK’s blue-chip index took a hit mostly from energy stocks and AstraZeneca. Over in the mid-caps, the FTSE 250 managed a 0.3% gain. London’s market direction isn’t just about corporate results anymore. Investors are juggling Middle East tensions, choppy oil, and a Bank of England that kept rates steady but dodged the tough calls on inflation. The FTSE 100 jumped 1.6% Thursday, Rolls-Royce and Glencore out front, but that bounce couldn’t turn the week around.
May 2, 2026
UK Stock Market Week Ahead: FTSE 100 Faces BoE Shock Test After First Weekly Loss in Five
········

UK Stock Market Week Ahead: FTSE 100 Faces BoE Shock Test After First Weekly Loss in Five

London’s stock market stays dark Sunday, but pressure is building for Monday’s open. The FTSE 100—fresh off its first weekly drop in five—faces a busy stretch, with Bank of England decisions and key earnings reports ahead. Trading on the London Stock Exchange runs 8:00 a.m. to 4:30 p.m. local, Monday through Friday. London’s FTSE 100 dropped 0.8% to end at 10,379.08 on Friday, with the FTSE 250 matching that 0.8% loss. Investors struggled with shaky U.S.-Iran relations, oil breaking above $100 a barrel, and a Bank of England warning that global equities might not be fully accounting for risk. Among the laggards: Barclays and HSBC slid, Wizz Air tumbled as pricier oil hammered airline shares, and AstraZeneca along with GSK
April 26, 2026
Drugmakers say AI is shaving weeks off clinical trials and regulatory submissions
········

Drugmakers say AI is shaving weeks off clinical trials and regulatory submissions

Drugmakers are increasingly relying on artificial intelligence to accelerate clinical trials and regulatory filings, slashing weeks off processes that often slow down development, according to executives and analysts. While AI hasn’t yet cracked the code for discovering groundbreaking new drugs, it’s already making a dent in the “messy middle” of drug development. This matters since the timeline remains brutal. Companies report that developing a drug can take around a decade and cost close to $2 billion. Even when results seem promising, the slow grind of trial setup and paperwork can drag timelines out much longer.
January 26, 2026
The AI-Driven Revolution Saving Factories Millions
········

Predictive Manufacturing: The AI-Driven Revolution Saving Factories Millions

Predictive manufacturing refers to using data and advanced analytics to foresee events in production and act before problems occur. In simple terms, factories collect data from machines and processes, analyze it with AI algorithms, and predict issues or outcomes in advance germanedge.com. This approach grew out of predictive maintenance – the practice of anticipating equipment failures – and extends the idea to entire operations. Instead of reacting to machine breakdowns or quality defects, predictive manufacturing lets companies fix anomalies before they impact product quality, yield or downtime my.avnet.com. For example, by continuously monitoring sensor data, a manufacturer can catch a slight vibration or temperature spike in a machine and intervene before it causes a breakdown. As one industry expert explains,
August 8, 2025